Exhibit 08 - FDA FOI Summary NADA 141-562 Librela (bedinvetmab) Approved (May 5 2023)
FDA-2026-P-6249-0010Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Exhibit 08 - FDA FOI Summary NADA 141-562 Librela (bedinvetmab) Approved (May 5 2023)
- Posted
- Jun 3, 2026